ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Conceptus, Inc. (MM)

Conceptus, Inc. (MM) (CPTS)

31.02
0.00
(0.00%)
Closed July 25 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

CPTS News

Official News Only

CPTS Discussion

View Posts
Penny Roger$ Penny Roger$ 12 years ago
~ Thursday! $CPTS ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $CPTS ~ Earnings expected on Thursday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=CPTS&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=CPTS&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=CPTS
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CPTS#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CPTS+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CPTS
Finviz: http://finviz.com/quote.ashx?t=CPTS
~ BusyStock: http://busystock.com/i.php?s=CPTS&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CPTS >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 12 years ago
Conceptus, Inc. is engaged in the design, development, marketing and promotion of solutions in women’s healthcare. The Company’s product, Essure permanent birth control system, is a non-surgical permanent birth control system. The Essure system delivers a soft and flexible insert into a woman’s fallopian tubes, causing a benign tissue in-growth which blocks the fallopian tubes. Successfully placed Essure micro-inserts and the subsequent tissue growth around and through the micro-inserts prohibits the egg from traveling through the fallopian tube, preventing conception. During the year ended December 31, 2010, approximately 500,000 women worldwide had undergone the Essure procedure and it sold the Essure system in 31 countries. In October 2011, the Company acquired from its Dutch distributor certain assets and all distribution rights of the Essure device.

http://www.google.com/finance?q=CPTS
👍️0